Scinovex
review Open AccessTop 1% cited

Meta‐analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes

British Journal of Clinical Pharmacology · 2004 · Vol. 57(5) · pp. 640–651
Bernard M.Y. CheungI LauderChu‐Pak LauCyrus R. Kumana

Abstract

Statins reduce coronary events, strokes and all-cause mortality without increasing noncoronary mortality. The benefits accrue in men and women, hypertensives and normotensives, diabetics and nondiabetics, and particularly in smokers. Pravastatin appears to have less impact on strokes.

Lipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismCardiac Imaging and DiagnosticsMedicinePravastatinInternal medicineStatinPlaceboRandomized controlled trialMeta-analysisRosuvastatinStroke (engine)Cholesterol

MeSH terms

Coronary DiseaseHumansSex FactorsSmokingRandomized Controlled Trials as TopicPravastatinHydroxymethylglutaryl-CoA Reductase InhibitorsStroke
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Meta‐analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes · Scinovex